Brief: Pharming Group FY Revenues Rises 3% To $205.6 Mln

Pharming

16/03/2023 06:15

March 16 (Reuters) - Pharming Group NV  PHAR.AS :
    * PHARMING GROUP REPORTS FINANCIAL RESULTS FOR FULL YEAR
2022
    * FY ROBUST CASH FLOWS FROM OPERATIONS OF US$22.9 MILLION
DROVE
OVERALL CASH BALANCE FROM US$193.0 MILLION TO US$208.7 MILLION
    * FY TOTAL REVENUES INCREASED BY 3% TO US$205.6 MILLION
    * FY OPERATING PROFIT INCREASED BY 34% TO US$18.2 MILLION
    * LENIOLISIB FDA REVIEW REMAINS ON TRACK WITH A PDUFA GOAL
DATE OF
MARCH 29, 2023
    * TOTAL NET PROFIT IN 2022 OF US$13.7 MILLION REPRESENTED A
DECREASE OF 14% OVER 2021 (US$16.0 MILLION)
    * CASH AND CASH EQUIVALENTS INCREASED TO US$208.7 MILLION AT
YEAR-END 2022

Source text for Eikon:  ID:nPre4KCCTa 
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;;))